PB 77 of 2022

National Health (Pharmaceutical Benefits Scheme - Exempt items - Section 84AH) Amendment Determination 2022 (No. 1)

NIKOLAI TSYGANOV

Contents

1  Name

2  Commencement

3  Authority

4  Schedules

Schedule — Amendments

National Health (Pharmaceutical Benefits Scheme–Exempt items – Section 84AH) Determination 2017 (PB 81 of 2017)

1  Name

  This instrument is the National Health (Pharmaceutical Benefits Scheme-Exempt items - Section 84AH) Amendment Determination 2022 (No. 1).

  This instrument may also be cited as PB 77 of 2022.

2  Commencement

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under section 84AH of the National Health Act 1953.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule — Amendments

National Health (Pharmaceutical Benefits Scheme–Exempt items – Section 84AH) Determination 2017 (PB 81 of 2017)

[1]  In the Schedule, after the entry for Mercaptopurine, Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL

             Omit: